Control of LDL-C levels after an acute coronary syndrome in Spain. Are the available treatments adequately used?

Rev Esp Cardiol (Engl Ed). 2021 Feb;74(2):194-196. doi: 10.1016/j.rec.2020.06.027. Epub 2020 Aug 10.

[Article in English, Spanish]

Authors

Manuel Anguita Sánchez¹, Juan J Gómez Doblas², Vivencio Barrios Alonso³

Affiliations

¹ Servicio de Cardiología, Hospital Universitario Reina Sofía, Córdoba, Spain; Servicio de Cardiología, Hospital Quirón Salud, Córdoba, Spain. Electronic address: manuelanguita@secardiologia.es.
² Servicio de Cardiología, Hospital Clínico Virgen de la Victoria, Málaga, Spain.
³ Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

PMID: 32792311
DOI: 10.1016/j.rec.2020.06.027

No abstract available

Publication types

Case Reports

MeSH terms

Acute Coronary Syndrome* / therapy
Cholesterol, LDL
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Risk Factors
Spain / epidemiology

Substances

Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors